Ardent Health Partners, LLC
Ardent Health Partners, LLC Fundamental Analysis
Ardent Health Partners, LLC (ARDT) shows moderate financial fundamentals with a PE ratio of 6.75, profit margin of 3.24%, and ROE of 17.09%. The company generates $6.4B in annual revenue with strong year-over-year growth of 10.29%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 43.1/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze ARDT's fundamental strength across five key dimensions:
Efficiency Score
WeakARDT struggles to generate sufficient returns from assets.
Valuation Score
ExcellentARDT trades at attractive valuation levels.
Growth Score
ModerateARDT shows steady but slowing expansion.
Financial Health Score
ModerateARDT shows balanced financial health with some risks.
Profitability Score
ModerateARDT maintains healthy but balanced margins.
Key Financial Metrics
Is ARDT Expensive or Cheap?
P/E Ratio
ARDT trades at 6.75 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, ARDT's PEG of -0.34 indicates potential undervaluation.
Price to Book
The market values Ardent Health Partners, LLC at 1.12 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -0.46 times EBITDA. This is generally considered low.
How Well Does ARDT Make Money?
Net Profit Margin
For every $100 in sales, Ardent Health Partners, LLC keeps $3.24 as profit after all expenses.
Operating Margin
Core operations generate 12.58 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $17.09 in profit for every $100 of shareholder equity.
ROA
Ardent Health Partners, LLC generates $3.98 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Ardent Health Partners, LLC generates limited operating cash flow of $370.85M, signaling weaker underlying cash strength.
Free Cash Flow
Ardent Health Partners, LLC generates weak or negative free cash flow of $157.77M, restricting financial flexibility.
FCF Per Share
Each share generates $1.10 in free cash annually.
FCF Yield
ARDT converts 11.03% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
6.75
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.34
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.12
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.22
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.84
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.08
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.17
vs 25 benchmark
ROA
Return on assets percentage
0.04
vs 25 benchmark
ROCE
Return on capital employed
0.19
vs 25 benchmark
How ARDT Stacks Against Its Sector Peers
| Metric | ARDT Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 6.75 | 29.45 | Better (Cheaper) |
| ROE | 17.09% | 779.00% | Weak |
| Net Margin | 3.24% | -24936.00% (disorted) | Weak |
| Debt/Equity | 1.84 | 0.26 | Weak (High Leverage) |
| Current Ratio | 2.08 | 4.65 | Strong Liquidity |
| ROA | 3.98% | -19344.00% (disorted) | Weak |
ARDT outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Ardent Health Partners, LLC's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
32.51%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
47.50%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
131.96%
Industry Style: Defensive, Growth, Innovation
High Growth